Why Monitor Neuromuscular Blockade?
Post-operative residual paralysis is an under-recognized event. Monitoring the effects of neuromuscular blocking drugs ensures their appropriate intra-operative use and helps prevent residual neuromuscular weakness.
The accepted definition for “adequate recovery” from neuromuscular block is the return of the train-of-four (TOF) ratio to, or above 0.9 (90%). This level of recovery restores most of the functional integrity of the muscles involved in airway protection.
The only reliable way of confirming adequate recovery from neuromuscular blockade and avoiding postoperative residual weakness is quantitative neuromuscular monitoring.
Prevent the preventable
Every year millions of patients are affected by postoperative respiratory complications. In US alone, more than 100.000 patients annually experience adverse events associated with undetected residual neuromuscular blockade.
Without a quantitative neuromuscular blockade monitor there is an increased risk of:
Proactive decision support
Knowing the current level of muscle paralysis will support you in making proactive and informed decisions concerning:
64%
of patients in a recent study experienced RNMB
+80 min
the lenght of stay in PACU increases by 80 minutes in patients with TOFR´s < 0.9
93%
of patients affected by a serious critical complication have RNMB.
X3
CRE´s were 3 times more likely in patients receiving NMBA´s with TOFR´s < 0.9
